Active	Status	Sponsor type	Region	Phase	Filter
7 Active 3 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Resar, Jon
NCT04482062: TRISCEND II Pivotal Trial	Active, not recruiting	N/A	1070	Europe, US	Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy	Edwards Lifesciences	Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure	06/24	12/29
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.	Recruiting	N/A	1056	Europe, Canada, US	Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)	Medtronic Cardiovascular	Mitral Valve Regurgitation	10/26	09/36
Bivalacqua, Trinity J
TURBT, NCT06111235: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following	Recruiting	3	364	Canada, US	Cretostimogene Grenadenorepvec, CG0070, n-dodecyl-B-D-maltoside, DDM	CG Oncology, Inc.	Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer, Urothelial Carcinoma	01/28	01/30
BRIDGE, NCT05538663: Intravesical BCG vs GEMDOCE in NMIBC	Recruiting	3	870	US	Gemcitabine, GEMZAR, Docetaxel, Taxotere, Bacillus Calmette Guerin, BCG	ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)	Non-muscle-invasive Bladder Cancer	11/29	10/30
NCT05399004: Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer	Completed	N/A	34	NA	Survey Administration	Mayo Clinic, National Cancer Institute (NCI)	Bladder Carcinoma	06/24	06/24
BLCCR, NCT02660645: Blue Light Cystoscopy With Cysview® Registry	Recruiting	N/A	4400	US	Hexaminolevulinate hydrochloride (HCL), Cysview®, Hexvix®, Karl Storz D-Light C Photodynamic Diagnostic (PDD) system	Photocure, Catalyst Pharmaceutical Research	Bladder Cancer	12/28	12/28
NCT03193970: Measuring Surgical Recovery After Radical Cystectomy	Recruiting	N/A	2000	US	Post-Operative Recovery Registry	M.D. Anderson Cancer Center	Bladder Cancer	12/34	12/34